Lack of Evidence for Oxidative Stress in Sporadic Amyotrophic Lateral Sclerosis Fibroblasts

被引:8
|
作者
Sala, Gessica [1 ]
Trombin, Federica [1 ]
Mattavelli, Laura [1 ,2 ]
Beretta, Simone [1 ,2 ]
Tremolizzo, Lucio [1 ,2 ]
Andreoni, Simona [1 ]
Calabrese, Elena [4 ]
Sanvito, Lara [4 ]
Ferrarese, Carlo [1 ,2 ,3 ]
机构
[1] Univ Milano Bicocca, Dept Neurosci & Biomed Technol, IT-20052 Monza, MI, Italy
[2] San Gerardo Hosp, Dept Neurol, Monza, Italy
[3] Sci Inst E Medea, Bosisio Parini, Italy
[4] Sci Inst Santa Maria Nascente Don Gnocchi, Milan, Italy
关键词
Amyotrophic lateral sclerosis; Fibroblasts; Reactive oxygen species; Protein carbonylation; Protein nitration; p38-mitogen-activated protein kinase; ACTIVATED PROTEIN-KINASE; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; GLUTAMATE UPTAKE; ALS PATIENTS; DAMAGE; 3-NITROTYROSINE; NITROTYROSINE; TISSUES; BLOOD;
D O I
10.1159/000121390
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: It is conceivable that an early therapeutic intervention in amyotrophic lateral sclerosis (ALS) would lead to better results in terms of disease progression for these patients. One possible strategy to increase the sensitivity of the diagnosis is represented by the use of biological parameters reflecting, for example, oxidative stress alterations associated with ALS. Such biomarkers would be valuable tools both for a better diagnostic evaluation and for studying the impact of therapeutic interventions on the disease course. A special category of experimental models is represented by peripheral cells obtained directly from patients (ex vivo). Objective: In this study, primary fibroblasts obtained from 10 sporadic ALS (SALS) patients and 10 healthy matched controls were used to investigate a panel of parameters related to the oxidative status. Methods: Reactive oxygen species production, protein carbonylation and nitration, susceptibility to hydrogen peroxide exposure, p38-mitogen-activated protein kinase activation and adenosine triphosphate intracellular content were evaluated. Results: No significant difference was observed in all investigated parameters between patient and control cells, and no correlation with the disease severity was found. Conclusion: Collectively, our data show no major alterations of the oxidative and bioenergetic status in SALS cultured fibroblasts, suggesting that these cells do not represent a useful model to study the oxidative dysfunction associated with SALS. Copyright (C) 2008 S. Karger AG, Basel
引用
收藏
页码:9 / 15
页数:7
相关论文
共 50 条
  • [31] Dysregulation of miRNAs in sporadic amyotrophic lateral sclerosis
    Figueroa-Romero, C.
    Hur, J.
    Bender, D. E.
    Cataldo, M.
    Flores, G.
    Smith, A. L.
    Yung, R.
    Callaghan, B. C.
    Feldman, E. L.
    MOLECULAR BIOLOGY OF THE CELL, 2013, 24
  • [32] Genetic variability in sporadic amyotrophic lateral sclerosis
    Van Daele, Sien Hilde
    Moisse, Matthieu
    van Vugt, Joke J. F. A.
    Zwamborn, Ramona A. J.
    van der Spek, Rick
    van Rheenen, Wouter
    Van Eijk, Kristel
    Kenna, Kevin
    Corcia, Philippe
    Vourc'h, Patrick
    Couratier, Philippe
    Hardiman, Orla
    McLaughin, Russell
    Gotkine, Marc
    Drory, Vivian
    Ticozzi, Nicola
    Silani, Vincenzo
    Ratti, Antonia
    de Carvalho, Mamede
    Mora Pardina, Jesus S.
    Povedano, Monica
    Andersen, Peter M.
    Weber, Markus
    Basak, Nazli A.
    Shaw, Chris
    Shaw, Pamela J.
    Morrison, Karen E.
    Landers, John E.
    Glass, Jonathan D.
    van Es, Michael A.
    van den Berg, Leonard H.
    Al-Chalabi, Ammar
    Veldink, Jan
    Van Damme, Philip
    BRAIN, 2023, 146 (09) : 3760 - 3769
  • [33] Mitochondrial haplogroups and sporadic amyotrophic lateral sclerosis
    Mancuso, M
    Siciliano, G
    Choub, A
    Filosto, M
    Quattrone, A
    Tessitore, A
    Sola, P
    Murri, L
    NEUROLOGY, 2005, 64 (06) : A203 - A203
  • [34] Cognitive impairment in sporadic amyotrophic lateral sclerosis
    Fedotova, L. F.
    Fedotov, V. V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 95 - 95
  • [35] Fungal Neurotoxins and Sporadic Amyotrophic Lateral Sclerosis
    Peter W. French
    Russell Ludowyke
    Gilles J. Guillemin
    Neurotoxicity Research, 2019, 35 : 969 - 980
  • [36] MicroRNA in Amyotrophic Lateral Sclerosis: Evidence for different pathophysiology in genetic and sporadic ALS
    Pegoraro, V.
    Giaretta, L.
    Angelini, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 633 - 633
  • [37] Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS)
    Zhang, RZ
    Gascon, R
    Miller, RG
    Gelinas, DF
    Mass, J
    Hadlock, K
    Jin, X
    Reis, J
    Narvaez, A
    McGrath, MS
    JOURNAL OF NEUROIMMUNOLOGY, 2005, 159 (1-2) : 215 - 224
  • [38] Evidence against increased oxidative stress in fibroblasts from patients with non-superoxide-dismutase-1 mutant familial amyotrophic lateral sclerosis
    Jansen, GA
    Wanders, RJA
    Jobsis, GJ
    Bolhuis, PA
    deJong, JMBV
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 139 : 91 - 94
  • [39] Lack of association between apolipoprotein E (APOE) genotype and sporadic amyotrophic lateral sclerosis (ALS).
    Siddique, T
    Pericak-Vance, MA
    Caliendo, J
    Hong, ST
    Hung, WY
    Kaplan, J
    McKenna-Yasek, D
    Rimmler, JB
    Sapp, P
    Saunders, AM
    Scott, WK
    Siddique, N
    Haines, JL
    Brown, RH
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A294 - A294
  • [40] Reduction of oxidative stress in amyotrophic lateral sclerosis following pramipexole treatment
    Pattee, GL
    Post, GR
    Gerber, RE
    Bennett, JP
    AMYOTROPHIC LATERAL SCLEROSIS, 2003, 4 (02): : 90 - 95